s / Osteoarthritis and Cartilage 21 (2013) S63–S312 S110 inadequate barium perfusion. Future studies of cartilage canals using SWI are likely to improve our understanding of the pathogenesis and progression of OC and other developmental orthopedic diseases by providing a non-invasive method to evaluate the vascular supply and associated pathology of the AECC. 191 VERIFICATION OF THREE DIFFERENT MMP-13 ISOFORMS EXPRESSION IN HUMAN OSTEOARTHRITIC CARTILAGE A. Farran y, L. Tio y, J. Monfort y, J.-P. Pelletier z, J. Martel-Pelletier x. y IMIM-Hosp. del Mar, Barcelona, Spain; zCtr. Hosp.ier de l'Universite de Montreal, Montreal, Montreal, QC, Canada; xDept. of Pharmacology, Dept. of Med., Montreal, QC, Canada Purpose: Collagenase-3 (MMP-13) is a human matrix metalloproteinase highly overexpressed in diseases where tissue repair and remodelling is needed, such as rheumatoid arthritis (RA), osteoarthritis (OA) and some cancers. However, its expression in normal tissues is limited to fetal ossification processes. MMP-13 can digest fibrillar collagen, preferentially type II collagen, but also glomerular collagens and other components of the extracellular matrix (ECM). MMP-13 structures is composed of 4 domains: a hydrophobic pre-domine necessary for the secretion, a pro-domain involved in enzyme latency, a catalytic domain, and a hemopexin-like domain This last is essential for the substrate recognition and collagenolytic activity. Three different MMP-13 transcripts of 3.0, 2.5 and 2.2/2.0 kb have been described to be expressed in human cells. The 2.5kb transcript (isoform 205) corresponds to the MMP-13 original form, while the 3.0kb transcript (isoform 344) presents an insertion at the C-terminal produced by lack of exon 9B splicing. Finally, the smaller transcript of 2.2/2.0kb (isoform 209) presents a deletion (probably due to alternative splicing) of 88 amino acids, also affecting the C-terminal domain. Our objective is to demonstrate the presence of these three MMP13 protein isoforms in human OA samples. Methods: A specific peptide from each isoform was synthesized and two rabbits were immunized with each peptide. The antibodies recognizing each isoform were purified from the total antiserum by sulfolink column. On the other hand MMP-13 isoforms were synthetized in vitro in a Sf9 insect cells system, with a recombinant baculovirus containing MMP-13 transcripts cloned. The insect cells were culture to produce the respective isoforms, and they were purified by molecular exclusion chromatography. These proteins were used to test the specificity of the polyclonal antibodies obtained by Western Blot. Finally, ECM proteins were extracted from cartilage samples obtained from knee and hip arthrosic patients undergoing arthroplasty, using Guanidinium chloride (4M) method. The presence of the 3 isoforms in these samples was assay by western blot with the specific isoform polyclonal antibodies obtained. Results: The purified polyclonal antibodies show immunoreactivity only in front of its specific isoform, showing that they are useful for the detection of each specific isoform in the samples. In all the samples tested, different intensities of the bands corresponding of each antibody were detected. No relative quantification could be performed due to the lack of a standard of each MMP-13 isoforms that allows us to compare the affinity of each polyclonal antibody to each specific isoform. Conclusions: The MMP-13 mRNA isoforms are translated to protein in cartilage OA samples. The transcripts containing the deleted and the alternatively spliced exons differ from the original sequence in the region coding for the hemopexin-like domain. This domain is necessary to cleave native triple helical collagens and provide to the protease its substrate specificity and affinity. The expression of 209 and 344 isoform could have clinical implications in OA if they present different subtracted recognition and/or speed of degradation, explaining some differences observed in the pathophysiology of the disease. 192 QUANTITATIVE ECHOGENICITY OF SMALL INTRA-ARTICULAR DEPOSITS OF CALCIUM, HYALINE CARTILAGE THICKNESS AND SONOGRAPHIC ASPECTS OF THE SYNOVIUM IN PATIENTS WITHOUT RADIOGRAPHIC CHONDROCALCINOSIS A. Checa y, H. Hussain y, E. Russell z. yDrexel Univ. Coll. of Med., Philadelphia, PA, USA; zChristiana Care Hlth.System, Newark, DE, USA Purpose: Ultrasonography is very helpful in the detection of intraarticular crystal deposits and also in distinguishing gout from chondrocalcinosis (CC). However, only three patients without CC on radiographies with evidence of calcium deposits within the cartilage detected by ultrasound (US) have been reported. Methods: In a cohort of 406 patients who underwent musculoskeletal US from January 2010 to June 2011, 30 patients with chondrocalcinosis were identified by the presence of calcium deposits using a machine equipped with an 8-13 MHz linear transducer. The presence of chondrocalcinosis was sonographically recognized as hyperechoic foci within the articular cartilage or fibrocartilage. Once aggregates of calcium were identified, the size was measured unless the deposit burden was too large to quantify. The quantitative echogenicity was assessed among all patients with chondrocalcinosis. A sampling of the area of the calcium aggregates with apparent highest echogenicity was matched with the gray scale bar and measured in a scale of 0 to 10 centimeters. In addition, cartilage thickness was measured on transverse view obtained with the knee fully flexed. In the same view, a minimal-crystal distance of the deposit (distance of the superior margin of the deposit to the cartilage surface) was calculated. Results: We identified 30 patients with US evidence of aggregates of calcium within the wrist or knee cartilage. Two patients were excluded from the study since prior radiographs of the joint were not available. Of the 28 patients included in the study, 9 (32%) showed radiographic evidence of chondrocalcinosis and 19 (68%) patients had no evidence of chondrocalcinosis on prior radiographs (p 1⁄4 0.001).Those patients with sonographic, but not radiographic CC, predominately had small calcium deposition [mean: 1.5mm (range: 0.8mm4.6mm)] vs. the group with radiographic CC that showed extensive deposition (Panel A). The group with radiographic CC showed deposits in more than one compartment (82%), which was observed in only 33% in the group with no radiographic CC. The patients with CC on x-ray had deposits with higher echogenicity (mean: 6.2) compared with those without (mean: 5.7). However, it was not statistically significant (p1⁄40.16). Cartilage thickness was not different between patients with or without radiographic CC [mean: 1.96mm vs. 2.0mm respectively, p1⁄40.84]. Patients without radiographic CC showed a small minimal-crystal distance [mean: 0.5 mm (range: 0-1.3mm)] compared with the group with CC on radiographies [mean: 0.8mm (range: 0.3-1.6)]. In the first group (21 knees), this distance was similar in presence or not of non-shadowing hyperechoic dots within the synovium or effusion [mean: 0.5mm vs. 0.4 mm, p1⁄40.25]. Effusion and synovial hypertrophy were detected in the majority of patients irrespective of the presence of small or extensive deposits of calcium. Roughly one-third of all patients showed hyperechoic dots within the synovium. The presence of dots within the effusion was detected in 42% in the group with occult CC vs. 33% with radiographic CC (Panel B, C and D). Ultimately, a calcified meniscus was identified in 26% of patients without radiographic CC. Conversely, all patients with radiographic evidence of CC showed a meniscocalcinosis sonographically (Panel B). Conclusions: Ultrasound was better than convectional radiography in detecting small deposits of calcium within the cartilage. Knee cartilage thickness was similar in both groups with and without radiographic CC. We speculate that small size of the calcium deposits, mainly localized in one compartment of the knee, lower echogenicity, and the low rate of